[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Reporting Amount of Listed Drugs and Biological Products Un...[ Price : $8.95]
Bloomberg News reports that FDA inspectors found problems at a Catalent Indiana facility that is being bought by Novo Nordisk to e...[ Price : $8.95]
FDA approves a Veru IND to begin a Phase 2b clinical study to evaluate enobosarm and its use in preserving muscle mass and physica...[ Price : $8.95]
A federal court sentences Arizona-based Centera Bioscience and CEO Paul Eftang for distributing unapproved drugs into interstate c...[ Price : $8.95]
Johnson & Johnson reports positive data from two studies involving its monoclonal antibody nipocalimab, supporting the drugs poten...[ Price : $8.95]
FDA posts a final guidance entitled Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C A...[ Price : $8.95]
Ainos files a clinical hold response seeking to begin a Phase 2 trial of its low-dose oral interferon (IFN)-alpha formulation Veld...[ Price : $8.95]
Federal Register notice: FDA announces a 3/21 advisory committee meeting to discuss a de novo marketing request by Balance Ophthal...